Abstract: A biostimulative illumination apparatus for treating patient tissues includes at least one light emitting diode which can generate at least one narrow-pulse focused wave band suitable to be used as low-power and non-parallel focused light beams for biostimulative illumination. The wave length of the focused light beam is from 600 nm to 850 nm, the energy density of the focused light beams is from 2 Joule/cm' to 16 Joule/cm' and the divergence angle of the light beams is between 1° to 7° that includes 1°, 2°, 3°, 4°, 5°, 6° and 7°.

Abstract: A driving device of a liquid crystal display (LCD) utilized for preventing noises of a clock signal from causing error operation of a shift register is disclosed. The driving device includes a shift register, a reception terminal, a noise elimination circuit and a control signal generation circuit. The reception terminal is utilized for receiving a first clock signal. The noise elimination circuit is coupled to the reception terminal, and is utilized for eliminating noises of the first clock signal and delaying the first clock signal for a preset time to generate a second clock signal. The control signal generation circuit is coupled to the reception terminal, the noise elimination circuit and the shift register, and is utilized for generating a first control signal and a second control signal to control the shift register.

Abstract: A driving device of a liquid crystal display (LCD) utilized for preventing noises of a clock signal from causing error operation of a shift register is disclosed. The driving device includes a shift register, a reception terminal, a noise elimination circuit and a control signal generation circuit. The reception terminal is utilized for receiving a first clock signal. The noise elimination circuit is coupled to the reception terminal, and is utilized for eliminating noises of the first clock signal and delaying the first clock signal for a preset time to generate a second clock signal. The control signal generation circuit is coupled to the reception terminal, the noise elimination circuit and the shift register, and is utilized for generating a first control signal and a second control signal to control the shift register.

Abstract: An all-digital clock generator includes a digitally-controlled clock generator and a processing unit. The digitally-controlled clock generator generates a clock signal in response to an enable signal and a digital signal. The processing unit has a frequency multiplier and a reference signal having a period, digitizes the period to generate a quantized signal, generates the digital signal according to the quantized signal and the frequency multiplier, and generates the enable signal according to the reference signal, the clock signal and the frequency multiplier.

Abstract: A biostimulative illumination apparatus for treating patient tissues includes at least one light emitting diode which can generate at least one narrow-pulse focused wave band suitable to be used as low-power and non-parallel focused light beams for biostimulative illumination. The wave length of the focused light beam is from 600 nm to 850 nm, the energy density of the focused light beams is from 2 Joule/cm2 to 16 Joule/cm2 and the divergence angle of the light beams is between 1° to 7° that includes 1°, 2°, 3°, 4°, 5°, 6° and 7°.

Abstract: A voltage comparator includes an input portion, an output portion, and a diverting portion. The input portion accepts a first voltage and a second voltage and then outputs a first current based on the first voltage and outputs a second current based on the second voltage. The output portion outputs a result signal based on a difference between the first current and the second current. The diverting portion is electrically connected to the input portion and diverts a portion of the higher current amongst the first current and the second current.

Abstract: A biostimulative illumination apparatus for treating patient tissues includes at least one light emitting diode which can generate at least one narrow-pulse focused wave band suitable to be used as low-power and non-parallel focused light beams for biostimulative illumination. The wave length of the focused light beam is from 600 nm to 850 nm, the energy density of the focused light beams is from 2 Joule/cm2 to 16 Joule/cm2 and the divergence angle of the light beams is smaller than 16°.

Abstract: A biostimulative illumination apparatus for treating patient tissues includes at least one light emitting diode which can generate at least one narrow-pulse focused wave band suitable to be used as low-power and non-parallel focused light beams for biostimulative illumination. The wave length of the focused light beam is from 600 nm to 850 nm, the energy density of the focused light beams is from 2 Joule/cm2 to 16 Joule/cm2 and the divergence angle of the light beams is lower than 16°. In addition, the invention also provides a biostimulative illumination treatment method.

Abstract: A driving device of a liquid crystal display (LCD) utilized for preventing noises of a clock signal from causing error operation of a shift register is disclosed. The driving device includes a shift register, a reception terminal, a noise elimination circuit and a control signal generation circuit. The reception terminal is utilized for receiving a first clock signal. The noise elimination circuit is coupled to the reception terminal, and is utilized for eliminating noises of the first clock signal and delaying the first clock signal for a preset time to generate a second clock signal. The control signal generation circuit is coupled to the reception terminal, the noise elimination circuit and the shift register, and is utilized for generating a first control signal and a second control signal to control the shift register.

Abstract: A data driving circuit for a low color wash-out liquid crystal display includes a serial-to-parallel conversion module for converting to output a plurality of sequentially received pixel data in parallel, a compensation data generation module for performing a function operation for the plurality of pixel data to generate a plurality of gamma compensation data, a digital-to-analog conversion module for performing digital-to-analog conversion for the plurality of pixel data and the plurality of gamma compensation data according to a gamma look-up table, and an operational amplifier module for generating a plurality of driving voltages of major pixels and a plurality of driving voltages of sub pixels according to analog signals outputted by the digital-to-analog conversion module to drive the major pixels and the sub pixels corresponding to a row of the liquid crystal display.

Abstract: A driving device of a gate driver in a flat panel display for reducing production cost includes a plurality of addressing units, each addressing unit for generating a plurality of addressing signals, and an output control circuit for performing logic operations in order on a plurality of addressing signals generated by one of the plurality of addressing units and a plurality of addressing signals generated by another of the plurality of addressing units, for generating a plurality of channel output signals.

Abstract: A biostimulative illumination apparatus for treating patient tissues includes at least one light emitting diode which can generate at least one narrow-pulse focused wave band suitable to be used as low-power and non-parallel focused light beams for biostimulative illumination. The wave length of the focused light beam is from 600 nm to 850 nm, the energy density of the focused light beams is from 2 Joule/cm2 to 16 Joule/cm2 and the divergence angle of the light beams is lower than 16°. In addition, the invention also provides a biostimulative illumination treatment method.

Abstract: In general, the invention features a method for selecting a transgenic grapevine or grapevine component having increased resistance to a grapevine fanleaf disease. The method involves (a) transforming a grape plant cell with a grapevine fanleaf virus coat protein nucleic acid molecule or fragment thereof which is expressed in the plant cell; (b) regenerating a transgenic grapevine or grapevine component from the plant cell; and (c) selecting a transgenic grapevine or grapevine component expressing a grapevine fanleaf virus coat protein or coat protein fragment thereof, where the coat protein or the coat protein fragment thereof is expressed at a level equal to or less than an optical density of about 0.2 at 405 nm as detected by an enzyme-linked immunoassay as compared to a control plant, the selected transgenic grapevine or grapevine component having resistance to the grapevine fanleaf disease.

Abstract: The present invention relates to isolated proteins or polypeptides of grapevine leafroll virus (type 2). The encoding DNA molecules either alone in isolated form or in an expression system, a host cell, or a transgenic grape plant are also disclosed. Other aspects of the present invention relates to a method of imparting grapevine leafroll resistance to grape and tobacco plants by transforming them with the DNA molecules of the present invention, a method of imparting beet yellows virus resistance to a beet plant, a method of imparting tristeza virus resistance to a citrus plant, and a method of detecting the presence of a grapevine leafroll virus, such as GRLaV-2, in a sample.

Abstract: The present invention relates to an isolated GLRaV-3 protein or polypeptide selected from a group of a polyprotein, a proteinase, a methyltransferase, a helicase, and an RNA-dependent RNA polymerase. The encoding DNA molecule either alone in isolated form or in an expression system, a host cell, or a transgenic grape plant is also disclosed. Another aspect of the present invention relates to a method of imparting grapevine leafroll resistance to grape plants by transforming them with the DNA molecule of the present invention.

Abstract: The invention features a method of detecting the presence of a grapevine leafroll virus in a sample using immunological or nucleic-acid based methodologies.

Abstract: The invention features antibodies, binding portions thereof, and probes which recognize grapevine leafroll virus proteins and polypeptides.

Abstract: The present invention relates to isolated proteins or polypeptides of grapevine leafroll virus (type 2). The encoding DNA molecules either alone in isolated form or in an expression system, a host cell, or a transgenic grape plant are also disclosed. Other aspects of the present invention relates to a method of imparting grapevine leafroll resistance, to grape and tobacco plants by transforming them with the DNA molecules of the present invention, a method of imparting beet yellows virus resistance to a beet plant, a method of imparting tristeza virus resistance to a citrus plant, and a method of detecting the presence of a grapevine leafroll virus, such as GRLaV-2, in a sample.

Abstract: In general, the invention features a method for selecting a transgenic grapevine or grapevine component having increased resistance to a fanleaf disease, the method including the steps of: (a) transforming a grape plant cell with a grape nepovirus coat protein nucleic acid molecule or fragment thereof which is capable of being expressed in the plant cell; (b) regenerating a transgenic grapevine or grapevine component from the plant cell; and (c) selecting a transgenic grapevine or grapevine component which expresses, at a low level, the nucleic acid molecule or fragment thereof, wherein the low level expression increases the resistance of the transgenic grapevine or grapevine component to fanleaf disease. The invention also relates to an isolated nucleic acid molecule encoding a coat protein or fragment thereof of a ‘Geneva’ isolate of a grapevine nepovirus virus.

Abstract: In general, the invention features a method for selecting a transgenic grapevine or grapevine component having increased resistance to a grapevine fanleaf disease. The method involves (a) transforming a grape plant cell with a grapevine fanleaf virus coat protein nucleic acid molecule or fragment thereof which is expressed in the plant cell; (b) regenerating a transgenic grapevine or grapevine component from the plant cell; and (c) selecting a transgenic grapevine or grapevine component expressing a grapevine fanleaf virus coat protein or coat protein fragment thereof, where the coat protein or the coat protein fragment thereof is expressed at a level equal to or less than an optical density of about 0.2 at 405 nm as detected by an enzyme-linked immunoassay as compared to a control plant, the selected transgenic grapevine or grapevine component having resistance to the grapevine fanleaf disease.